Coreg

Carvedilol, marketed under the trade name Coreg, is a beta blocker prescribed primarily for the treatment of congestive heart failure. It has also been used to manage high blood pressure and as a response to left ventricular dysfunction after a heart attack. In its original form, it was approved by the FDA in 1995. An extended-release formulation was approved in 2006.

Studies have shown that Coreg poses serious risks to anyone with asthma or asthma-type conditions, as it may impede the opening of airways and can lead to suffocation. Other reported side effects include low blood pressure, a diminished heart rate, fatigue or weakness, weight gain, diarrhea and dizziness. Tests have also shown that Coreg can mask symptoms of low blood sugar.

If you or someone you love bought Coreg, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.